SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-000060
Filing Date
2020-01-02
Accepted
2020-01-02 16:04:00
Documents
2
Period of Report
2019-12-26
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200102_8k.htm 8-K 32877
2 EXHIBIT 16.1 ex_168498.htm EX-16.1 3895
  Complete submission text file 0001437749-20-000060.txt   38278
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 20501516
SIC: 2836 Biological Products, (No Diagnostic Substances)